Metabolic Disorders News and Research

RSS

Increlex - first major innovation in 20 years for the treatment of growth failure

Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.

26 Sep 2005

Study reveals critical molecular events in the origin of fat cells

A new study reveals critical molecular events in the origin of fat cells. The findings are central to understanding chronic diseases, such as obesity and diabetes, as fat cells produce hormones critical for metabolic control, the researchers said.

21 Sep 2005

Human fat cells produce a protein that is linked to both inflammation and an increased risk of heart disease and stroke

Researchers at The University of Texas M. D. Anderson Cancer Center and The University of Texas Health Science Center at Houston have found that human fat cells produce a protein that is linked to both inflammation and an increased risk of heart disease and stroke.

19 Sep 2005

Obese men may not process carbohydrates as efficiently as obese women

Obese men may not process carbohydrates as efficiently as obese women, a condition that can, ultimately, lead to a decrease in fitness level and the development of metabolic disorders.

12 Jul 2005

Obese men may not process carbohydrates as efficiently as obese women

A new study published in the July issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), showed that severely obese men were more carbohydrate intolerant and had less physical endurance than severely obese women, leading researchers to believe that gender plays a strong role in physical fitness and a person's ability to metabolize carbohydrates.

11 Jul 2005

Pregnancy and birth factors may determine likelihood of polycystic ovarian syndrome

New research suggests that the way baby girls develop in the womb may affect whether or not they develop polycystic ovarian syndrome (PCOS) as adults and the severity of the symptoms if they do.

27 Jun 2005

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

The reported results of a one-year phase III study in 1045 people with type 2 diabetes treated with rimonabant, the first in a new class of therapeutic agents called selective CB1 Blockers, were that rimonabant 20 mg significantly improved HbA1c (a measure of blood sugar control), dyslipidemia (abnormal levels of fat in the blood), and systolic blood pressure with a concomitant substantial reduction in abdominal obesity in people with type 2 diabetes treated with oral anti-diabetic medications and requiring further control.

12 Jun 2005

Link between insomnia and obesity

A possible link between lack of sleep (insomnia) and obesity has been traced to hypocretin/orexin cells in the hypothalamus region of the brain that are easily excited and sensitive to stress, Yale School of Medicine researchers report in the April issue of Cell Metabolism.

13 Apr 2005

Growth hormone treatment may reduce serious metabolic conditions

Researchers in Sweden have discovered that growth hormone (GH) treatment may result in the reduction of multiple metabolic disorders associated with abdominal obesity in postmenopausal women.

14 Mar 2005

Pediatric obesity is now recognized as a major medical and health problem all over the world

A consensus statement on childhood obesity was published today in The Journal of Clinical Endocrinology & Metabolism, one of the four journals of The Endocrine Society.

8 Mar 2005

Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women

Researchers in Sweden have discovered that growth hormone (GH) treatment may result in the reduction of multiple metabolic disorders associated with abdominal obesity in postmenopausal women.

8 Mar 2005

Bush Administration opens the door to the elimination of critical health services for the most vulnerable women, infants and children

"The budget proposal released by the Administration this morning opens the door to the elimination of critical health services for the most vulnerable women, infants and children. The March of Dimes strongly opposes any attempt to narrow Medicaid benefits for these at risk groups.

7 Feb 2005

A single change in a person’s DNA can contribute to a range of life-shortening risk factors

A woman with hypertension, low magnesium levels, and a cooperative family allowed scientists to pinpoint the mutation, which affects the genes of the mitochondria — the energy-producing power plants of the cell that are passed from mother to offspring.

25 Oct 2004

Research opens new possibilities for the treatment of metabolic disorders such as diabetes and obesity

For the first time, researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected with the Catholic University of Leuven have shown clearly that receptors in yeast cells detect and react to nutrients in the cell.

21 Oct 2004

Women with the Polycystic Ovary Syndrome (PCOS) are at greatest risk for diabetes and coronary artery disease

A new position statement issued today by the American Association of Clinical Endocrinologists (AACE) states that women with the Polycystic Ovary Syndrome (PCOS) are at greatest risk for diabetes and coronary artery disease.

6 Oct 2004

Interleukin-6 has potential as a therapeutic drug in treating metabolic disorders such as obesity, type 2 diabetes and atherosclerosis

For the most of the past century, researchers have searched for a muscle-contraction-induced factor, which mediates some of the exercise effects in other tissues and organs such as the liver and adipose tissue.

5 Oct 2004

Genetic mutation link to sudden infant death syndrome

Researchers at Rush University Medical Center, and colleagues at the University of Pittsburgh have identified mutations in genes pertinent to the autonomic nervous system among babies who died of sudden infant death syndrome (SIDS) that might explain why they died.

21 Aug 2004

Metabolic Disorders News and Research

Increlex - first major innovation in 20 years for the treatment of growth failure

Study reveals critical molecular events in the origin of fat cells

Human fat cells produce a protein that is linked to both inflammation and an increased risk of heart disease and stroke

Obese men may not process carbohydrates as efficiently as obese women

Obese men may not process carbohydrates as efficiently as obese women

Pregnancy and birth factors may determine likelihood of polycystic ovarian syndrome

Rimonabant study shows significant improvements in HbA1c and cardiometabolic risk factors in people with type 2 diabetes

Link between insomnia and obesity

Growth hormone treatment may reduce serious metabolic conditions

Pediatric obesity is now recognized as a major medical and health problem all over the world

Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women

Bush Administration opens the door to the elimination of critical health services for the most vulnerable women, infants and children

A single change in a person’s DNA can contribute to a range of life-shortening risk factors

Research opens new possibilities for the treatment of metabolic disorders such as diabetes and obesity

Women with the Polycystic Ovary Syndrome (PCOS) are at greatest risk for diabetes and coronary artery disease

Interleukin-6 has potential as a therapeutic drug in treating metabolic disorders such as obesity, type 2 diabetes and atherosclerosis

Genetic mutation link to sudden infant death syndrome

Geneticists have closed in on the genetic basis for risk factors of metabolic diseases

U-M scientists say Wnt protein prevents obesity by inhibiting fat cell development

Drug for multiple sclerosis prevented disease development when tested on animal models

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News